ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

Cooney to Oversee University of Michigan Clinical Operations

February 7, 2013

Cancer Control Grows Up Fast As It Moves To Meet Mandate, Take Over Big Part Of NCI Budget

March 15, 1974

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

Texas Voters Approve $3 Billion In Bonds For Cancer Research.

November 9, 2007

William Nelson Named Cancer Center Director At Johns Hopkins.

November 7, 2008

NCAB To Study Recommendations On Cooperative Groups, Coordination Of NCI Treatment Programs

June 20, 1975